MAX Chat
China Shineway Pharmaceutical Group Limited
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
9/10
|
8.21 | 37.2 | -77.91% | 9.26 | -11.31% |
| P/S |
|
1.83 | 4.03 | -54.68% |
|
|
| P/BV |
|
0.9242 | 1.93 | -52.23% |
|
|
| P/FCF |
|
7.44 | -10.12 | -173.5% |
|
|
| Ev/Ebitda |
|
0.6 | 2.91 | -79.37% |
|
|
| Ev/S |
|
0.1758 | 7.34 | -97.6% |
|
|
| Ev/FCF |
|
0.807 | -11 | -107.34% |
|
|
| E/P |
|
0.1373 | 0.0327 | 319.26% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
8/10
|
29.21 | 1.46 | 1900.96% | 25.93 | +12.65% |
| ROE |
|
11.59 | 3.98 | 191.41% |
|
|
| ROA |
|
8.57 | 2.89 | 196.62% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
22.24 | 10.86 | 104.77% |
|
|
| ROCE |
|
0 | 0.1527 | -100% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0.0067 | 0.3827 | -98.25% | 0.0509 | -86.82% |
| Nеt Debt/Ebitda |
|
0 | -0.2202 | -100% |
|
|
| Debt/Ratio |
|
0.000737 | 0.132 | -99.44% |
|
|
| Debt/Equity |
|
0.3448 | 0.6875 | -49.85% |
|
|
| Debt/Net Income |
|
0.0088 | 2.61 | -99.66% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
10/10
|
7.04 | 4.32 | 63.13% | 9.63 | -26.91% |
| Number of years of dividend growth |
|
2 | 1.23 | 62.71% | ||
| DSI |
|
0.7857 | 0.5482 | 43.33% |
|
|
| Average dividend growth |
|
11.45 | -2.77 | -512.72% |
|
|
| Average percentage for 5 years |
|
9.63 | 4.29 | 124.62% |
|
|
| Average percentage for payments |
|
46.24 | 34.1 | 35.61% |
|
|
| Difference from average difference in sector |
|
2.72 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
6/10
|
42.26 | -94.75 | -144.6% | ||
| Growth impulse Ebitda in 5 years |
|
109.23 | -45.56 | -339.75% | ||
| Growth impulse Net Income in 5 years |
|
184.73 | -111.86 | -265.14% | ||
| Growth impulse FCF in 5 years |
|
43.75 | -138.06 | -131.69% | ||
| Growth impulse EPS in 5 years |
|
211.68 | -139.77 | -251.45% |
IP Score
7.96/10
